Clinical Trial Update: Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 study evaluating the combination of cixutumumab and temsirolimus in locally recurrent or metastatic breast cancer, including male breast cancer;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Cixutumumab (Cixutumumab)
• Temsirolimus (temsirolimus)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Male Breast Carcinoma, Recurrent Breast Carcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-05-21